Key Insights of Preclinical Imaging Market to 2021 - Global Major Manufacturers Production and Sales Market Comparison
The preclinical imaging market is fairly competitive, with a large number of global and local manufacturers of preclinical imaging solutions. PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), and FUJIFILM Holding Corporation (Japan) were top three play
(EMAILWIRE.COM, December 07, 2018 ) The Preclinical Imaging market is expected to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016 to 2021. Preclinical Imaging (In-VIVO) Market report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW) for the forecast period of 2016 to 2021.
Get Free Market Updates Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=673859 .
The preclinical imaging market is fairly competitive, with a large number of global and local manufacturers of preclinical imaging solutions. PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), and FUJIFILM Holding Corporation (Japan) were the top three players in the preclinical imaging market.
Competitive Landscape
1 Overview
2 Preclinical Imaging Market Share Analysis, By Key Player, 2015
3 Competitive Scenario
4 New Product Launches
5 Agreements, Partnerships, and Collaborations
6 Geographical Expansions
7 Acquisitions
Market growth in global preclinical imaging market is mainly driven by factors such technological advancements in field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches.
Get Upto 25% Discount Now at https://www.reportsnreports.com/contacts/discount.aspx?name=673859 .
Geographically, North America is estimated to command largest share of global Preclinical Imaging (In-VIVO) Market in 2016, followed by Europe. Large market share of the North American region can be attributed to the robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems.
Key Target Audience:
Preclinical Imaging Instrument Manufacturers, Suppliers, and Imaging Software Providers
Pharmaceutical and Biotechnology Companies
Preclinical Imaging Reagent Manufacturers and Suppliers
Contract Research Organizations (CROs)
Research and Development (R&D) Companies
Government Research Laboratories
Independent Research Laboratories
Government and Independent Regulatory Authorities
Market Research and Consulting Service Providers
Medical Research Laboratories
Academic Medical Institutes and Universities
Market growth in the global Preclinical Imaging (In-VIVO) Market is mainly driven by factors such technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches. In addition, emerging markets (such as China and India) are offering new growth opportunities for preclinical imaging market players.
More Information on Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast to 2021 report @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=673859 .
The report studies preclinical imaging market based on modality and reagents; utilized for the assessment of anatomical, physiological, and functional parameters at molecular and cellular levels in live animal models. These imaging systems and reagents are applied to visualize living animals during preclinical research studies in order to assess the safety and efficacy of novel drug procedures or other medical treatments for human applications.
Get Free Market Updates Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=673859 .
The preclinical imaging market is fairly competitive, with a large number of global and local manufacturers of preclinical imaging solutions. PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), and FUJIFILM Holding Corporation (Japan) were the top three players in the preclinical imaging market.
Competitive Landscape
1 Overview
2 Preclinical Imaging Market Share Analysis, By Key Player, 2015
3 Competitive Scenario
4 New Product Launches
5 Agreements, Partnerships, and Collaborations
6 Geographical Expansions
7 Acquisitions
Market growth in global preclinical imaging market is mainly driven by factors such technological advancements in field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches.
Get Upto 25% Discount Now at https://www.reportsnreports.com/contacts/discount.aspx?name=673859 .
Geographically, North America is estimated to command largest share of global Preclinical Imaging (In-VIVO) Market in 2016, followed by Europe. Large market share of the North American region can be attributed to the robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems.
Key Target Audience:
Preclinical Imaging Instrument Manufacturers, Suppliers, and Imaging Software Providers
Pharmaceutical and Biotechnology Companies
Preclinical Imaging Reagent Manufacturers and Suppliers
Contract Research Organizations (CROs)
Research and Development (R&D) Companies
Government Research Laboratories
Independent Research Laboratories
Government and Independent Regulatory Authorities
Market Research and Consulting Service Providers
Medical Research Laboratories
Academic Medical Institutes and Universities
Market growth in the global Preclinical Imaging (In-VIVO) Market is mainly driven by factors such technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches. In addition, emerging markets (such as China and India) are offering new growth opportunities for preclinical imaging market players.
More Information on Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast to 2021 report @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=673859 .
The report studies preclinical imaging market based on modality and reagents; utilized for the assessment of anatomical, physiological, and functional parameters at molecular and cellular levels in live animal models. These imaging systems and reagents are applied to visualize living animals during preclinical research studies in order to assess the safety and efficacy of novel drug procedures or other medical treatments for human applications.
Contact Information:
ReportsnReports
Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results